Severe hypomagnesaemia with tetany following ESHAP protocol
BACKGROUND: One patient with B-cell Non-Hodgkin's Lymphoma developed severe hypomagnesaemia and tetany 15 days after the first course of treatment with ESHAP protocol. This prompted a careful look at the incidence and severity of hypomagnesaemia during treatment with this combination chemotherapy. M...
保存先:
| 出版年: | BMC Blood Disord |
|---|---|
| 第一著者: | |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2002
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC64621/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11801194/ https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2326-2-1 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|